Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic Aorta

Circulation

Volumn 120, Issue SUPPL. 1, 2009, Pages

  Ruddy, Jean Marie ^a,b   Jones, Jeffrey A ^a,b   Stroud, Robert E ^a,b   Mukherjee, Rupak ^a,b   Spinale, Francis G ^a,b   Ikonomidis, John S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiotensin; Aorta; Metalloproteinases; Wall stress

Indexed keywords

ANGIOTENSIN II; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; ANGIOTENSIN 1 RECEPTOR; MMP14 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE TENSION; HYPERTENSION; MALE; MECHANICAL STIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; THORACIC AORTA; VASCULAR RING; ANIMAL; DRUG EFFECT; ENZYMOLOGY; GENETICS; MECHANICAL STRESS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; FEMALE; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; PROMOTER REGIONS, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; STRESS, MECHANICAL;

EID: 70349783878     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.843581     Document Type: Article

References (50)

1. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90: 251-262.
2. Lehoux S, Lemarie CA, Esposito B, Lijnen HR, Tedgui A. Pressureinduced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation, 2004;109:1041-1047. (Pubitemid 38282859)
3. Eagleton MJ, Ballard N, Lynch E, Srivastava SD, Upchurch GR Jr, Stanley JC. Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation. J Surg Res. 2006;135:345-351. (Pubitemid 44414882)
4. Abbruzzese TA, Guzman RJ, Martin RL, Yee C, Zarins CK, Dalman RL. Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model. Surgery. 1998;124:328-334. (Pubitemid 28372934)
5. Chakraborti S, Mandai M, Das S, Mandai A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem, 2003;253: 269-285.
6. Ruddy J, Jones J, Stroud R, Mukherjee R, Spinale F, Ikonomidis J. Differential effect of wall tension on matrix metalloproteinase promoter activation in the thoracic aorta. J Surg Res. 2009, Jan 24 [Epub ahead of print].
7. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003; 92:827-839. (Pubitemid 36542523)
8. Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol. 2006;206:1-8. (Pubitemid 41740711)
9. Nollendorfs A, Greiner TC, Nagase H, Baxter BT. The expression and localization of membrane type-1 matrix metalloproteinase in human, abdominal aortic aneurysms. / Vase Surg. 2001;34:316-322. (Pubitemid 33661130)
10. Sinha I, Hannawa KK, Eliason JL, Ailawadi G, Deogracias MP, Bethi S, Ford JW, Roelofs KJ, Grigoryants V, Henke PK, Stanley JC, Upchurch GR Jr. Early MT-1 MMP expression following elastase exposure is associated with, increased cleaved MMP-2 activity in experimental rodent aortic aneurysms. Surgery. 2004;136:176-182. (Pubitemid 39037651)
11. Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin, and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37: 1047-1052.
12. CokerML,JollyJR,JoffsC,EtohT,HolderJR,BondBR,SpinaleFG. Matrixmetalloproteinaseexpressionandactivity inisolatedmyocytesafterneurohormonalstimulation.AmJPhysiolHeartCircPhysiol. 2001;281:H543-H551.(Pubitemid32756076)
13. Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, Kranzhofer R. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vase Res. 2005;42:415-423. (Pubitemid 41368960)
14. Wang M, Takagi G, Asai K, Resuello RG, Natividad FF, Vatner DE, Vatner SF, Lakatta EG. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension. 2003;41:1308-1316. (Pubitemid 36706082)
15. Rosen. B, Barg J, Zimlichman R. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from, young normotensive and spontaneously hypertensive rats. Am J Hypertens. 1999;12:1243-1251. (Pubitemid 30029288)
16. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced. hypertrophy in vascular smooth muscle cells. J Biol Chem, 1996;271: 23317-23321. (Pubitemid 26314775)
17. Luchtefeld M, Grote K, Grothusen C, Bley S, Bandlow N, Selle T, Struber M, Haverich A, Bavendiek U, Drexler H, Schieffer B. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun. 2005;328:183-188. (Pubitemid 40164653)
18. Mukherjee R, Mingoia JT, Bruce JA, Austin JS, Stroud RE, Escobar GP, McClister DM Jr, Allen CM, Alfonso-Jaume MA, Fini ME, Lovett DH, Spinale FG. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006;291: H2216-H2228. (Pubitemid 44776648)
19. Mohan. R, Rinehart WB, Bargagna-Mohan P, Fini ME. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling. J Biol Chem. 1998; 273:25903-25914. (Pubitemid 28475821)
20. Swafford AN Jr, Harrison-Bernard LM, Dick GM. Knockout mice reveal that the angiotensin II type IB receptor links to smooth muscle contraction. Am J Hypertens. 2007;20:335-337.
21. HeGW,AngusJA,RosenfeldtFL.Reactivityofthecanineisolated, internalmammaryartery,saphenousvein,andcoronaryartery- constrictoranddilatorsubstances:relevance-coronarybypassgraftsurgery. JCardiovascPharmacol.1988;12:12-22.(Pubitemid18167911)
22. LalliJ,HarrerJM,LuoW,KraniasEG,PaulRJ. Targetedablationofthephospholambangeneisassociated, withamarkeddecreaseinsensitivityinaorticsmoothmuscle.CircRes.1997;80:506-513. (Pubitemid27137287)
23. BrandesRP,KimD,Schmitz-WinnenthalFH,AmidiM,GodeckeA,MulschA,BusseR. Increasednitrovasodilatorsensitivityinendo thelialnitricoxidesynthaseknockoutmice:roleofsolubleguanylylcyclase. Hypertension.2000;35:231-236.(Pubitemid30054178)
24. Freay AD, Curtis SW, Korach KS, Rubanyi GM. Mechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta: role of nuclear estrogen receptor and Ca2- uptake Circ Res. 1997;81: 242-248.
25. ZhouY,DirksenWP,BabuGJ,PeriasamyM. Differentialvasoconstrictionsinducedbyangiotensin.II: roleofATIandAT2receptorsinisolatedC57BL/6Jmousebloodvessels. AmJPhysiolHeartCircPhysiol.2003;285:H2797-H2803.(Pubitemid37443101)
26. Stacy LB, Yu Q, Horak K, Larson DF. Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities. Perfusion. 2007;22: 51-55. (Pubitemid 47018362)
27. Shaw A, Xu Q. Biomechanical stress-induced signaling in smooth muscle cells: an update. Curr Vase Pharmacol. 2003;1:41-58.
28. Oktay M, Wary KK, Dans M, Birge RB, Giancotti FG. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2terminal kinase and progression through, the G1 phase of the cell cycle. J Cell Biol. 1999;145:1461-1469. (Pubitemid 29310003)
29. Li C, Xu Q. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal. 2000;12:435-445.
30. HishikawaK,OemarBS,YangZ,LuscherTF. Pulsatilestretchstimulatessuperoxideproductionandactivatesnuclearfactor- kappaBinhumancoronarysmoothmuscle.CircRes.1997;81:797-803.(Pubitemid27467214)
31. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation. 2003;108:1253-1258. (Pubitemid 37099996)
32. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
33. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, Berk. BC. Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res. 1995;77:1053-1059.
34. SabriA,GovindarajanG,Griffin.TM,ByronKL,SamarelAM,LucchesiPA. Calcium-andproteinkinaseC- dependentactivationofthetyrosinekinasePYK2byangiotensin. IIinvascularsmoothmuscle.CircRes.1998;83:841-851.(Pubitemid28489081)
35. Duff JL, Berk. BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1992;188:257-264.
36. GovindarajanG,EbleDM,LucchesiPA,SamarelAM. FocaladhesionkinaseisinvolvedinangiotensinII-mediatedprotein, synthesisinculturedvascularsmoothmusclecells.CircRes.2000;87:710-716. (Pubitemid30778320)
37. GriendlingKK,MinieriCA,OllerenshawJD,AlexanderRW. AngiotensinIIstimulatesNADHandNADPHoxidaseactivityin culturedvascularsmoothmusclecells.CircRes.1994;74:1141-1148.(Pubitemid24176909)
38. HannaIR,TaniyamaY,SzocsK,RocicP,GriendlingKK.NAD(P)Hoxidase- derivedreactiveoxygenspeciesasmediatorsofangiotensinIIsignaling.Antioxid. RedoxSignal.2002;4:899-914.(Pubitemid36042466)
39. BlumeA,HerdegenT,UngerT.Angiotensin, peptidesandinducibletranscriptionfactors.JMolMed.1999;77:339-357. (Pubitemid29144070)
40. Hiroi Y, Hiroi J, Kudoh S, Yazaki Y, Nagai R, Komuro I. Two distinct mechanisms of angiotensin II-induced negative regulation of the mitogenactivated protein kinases in cultured cardiac myocytes. Hypertens Res. 2001;24:385-394. (Pubitemid 32792438)
41. SawardL,ZahradkaP.AngiotensinIIactivatesphosphatidylinositol3- kinaseinvascularsmoothmusclecells.CircRes.1997;81:249-257.(Pubitemid27342492)
42. Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer. 2002;2:657-672. (Pubitemid 37328917)
43. HaasTL,StitelmanD,DavisSJ,ApteSS,MadriJA.Egr- 1mediatesextracellularmatrix-driventranscription, ofmembranetype1matrixmetalloproteinaseinendothelium..JBiolChem.1999;274: 22679-22685.(Pubitemid129529289)
44. Park MJ, Kwak HJ, Lee HC, Yoo DH, Park IC, Kim MS, Lee SH, Rhee CH, Hong SI. Nerve growth, factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression, through the phosphatidylinositol 3-kinase/Akt signaling pathway and. AP-2 transcription, factor. J Biol Chem. 2007;282:30485-30496.
45. PimentelDR,AminJK,XiaoL,MillerT,ViereckJ,Oliver-KrasinskiJ,BaligaR,WangJ, SiwikDA,SinghK,PaganoP,ColucciWS,SawyerDB.Reactiveoxygenspeciesmediateamplitude- dependenthypertrophicandapoptoticresponses-mechanicalstretch,incardiacmyocytes. CircRes.2001;89:453-460.(Pubitemid34132662)
46. Pan CH, Wen CH, Lin. CS. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes. Exp Physiol, 2008;93:599-612.
47. Raffetto JD, Qiao X, Koledova VV, Khalil RA. Prolonged, increases in vein wall tension increase matrix metalloproteinases and decrease constriction, in rat vena cava: Potential implications in varicose veins. J Vase Surg. 2008;48:447-456.
48. Spruill LS, Lowry AS, Stroud RE, Squires CE, Mains IM, Flack EC, Beck C, Ikonomidis JS, Crumbley AJ, McDermott PJ, Spinale FG. Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy. Am J Physiol Cell Physiol. 2007;293:C1362-C1373. (Pubitemid 47556744)
49. Ailawadi G, Knipp BS, Lu G, Roelofs KJ, Ford JW, Hannawa KK, Bishop K, Thanaporn P, Henke PK, Stanley JC, Upchurch GR Jr. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vase Surg. 2003;37:1059-1066. (Pubitemid 36538932)
50. Schmoker JD, McPartland KJ, Bellinger EK, Boyum J, Trombley L, Ittleman FP, Terrien C III, Stanley A, Howard A. Matrix metalloproteinase and tissue inhibitor expression, in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2007; 133: 155-161. (Pubitemid 46014197)